425 related articles for article (PubMed ID: 30822410)
1. No correlation between serum testosterone levels and state-level anger intensity in transgender people: Results from the European Network for the Investigation of Gender Incongruence.
Defreyne J; Kreukels B; T'Sjoen G; Staphorsius A; Den Heijer M; Heylens G; Elaut E
Horm Behav; 2019 Apr; 110():29-39. PubMed ID: 30822410
[TBL] [Abstract][Full Text] [Related]
2. Sexual Desire Changes in Transgender Individuals Upon Initiation of Hormone Treatment: Results From the Longitudinal European Network for the Investigation of Gender Incongruence.
Defreyne J; Elaut E; Kreukels B; Fisher AD; Castellini G; Staphorsius A; Den Heijer M; Heylens G; T'Sjoen G
J Sex Med; 2020 Apr; 17(4):812-825. PubMed ID: 32008926
[TBL] [Abstract][Full Text] [Related]
3. Does Testosterone Treatment Increase Anger Expression in a Population of Transgender Men?
Motta G; Crespi C; Mineccia V; Brustio PR; Manieri C; Lanfranco F
J Sex Med; 2018 Jan; 15(1):94-101. PubMed ID: 29175227
[TBL] [Abstract][Full Text] [Related]
4. Prospective Evaluation of Self-Reported Aggression in Transgender Persons.
Defreyne J; T'Sjoen G; Bouman WP; Brewin N; Arcelus J
J Sex Med; 2018 May; 15(5):768-776. PubMed ID: 29699761
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence.
Defreyne J; Vantomme B; Van Caenegem E; Wierckx K; De Blok CJM; Klaver M; Nota NM; Van Dijk D; Wiepjes CM; Den Heijer M; T'Sjoen G
Andrology; 2018 May; 6(3):446-454. PubMed ID: 29602229
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of testicular function and spermatogenesis in transgender women.
Vereecke G; Defreyne J; Van Saen D; Collet S; Van Dorpe J; T'Sjoen G; Goossens E
Hum Reprod; 2021 Jan; 36(1):5-15. PubMed ID: 33257947
[TBL] [Abstract][Full Text] [Related]
7. Positive and Negative Affect Changes during Gender-Affirming Hormonal Treatment: Results from the European Network for the Investigation of Gender Incongruence (ENIGI).
Matthys I; Defreyne J; Elaut E; Fisher AD; Kreukels BPC; Staphorsius A; Den Heijer M; T'Sjoen G
J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33466910
[TBL] [Abstract][Full Text] [Related]
8. Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence.
Defreyne J; Aers XP; Collet SM; Wiepjes CM; Fisher AD; Schreiner T; Den Heijer M; Kaufman JM; T'Sjoen GGR
LGBT Health; 2020; 7(2):71-81. PubMed ID: 32049583
[No Abstract] [Full Text] [Related]
9. Vaginal bleeding and spotting in transgender men after initiation of testosterone therapy: A prospective cohort study (ENIGI).
Defreyne J; Vanwonterghem Y; Collet S; Iwamoto SJ; Wiepjes CM; Fisher AD; Schreiner T; Heijer MD; T'Sjoen G
Int J Transgend Health; 2020 Feb; 21(2):163-175. PubMed ID: 32935087
[TBL] [Abstract][Full Text] [Related]
10. Sexual orientation in transgender individuals: results from the longitudinal ENIGI study.
Defreyne J; Elaut E; Den Heijer M; Kreukels B; Fisher AD; T'Sjoen G
Int J Impot Res; 2020 Nov; 33(7):694-702. PubMed ID: 33483604
[TBL] [Abstract][Full Text] [Related]
11. Effects of testosterone therapy on constructs related to aggression in transgender men: A systematic review.
Kristensen TT; Christensen LL; Frystyk J; Glintborg D; T'Sjoen G; Roessler KK; Andersen MS
Horm Behav; 2021 Feb; 128():104912. PubMed ID: 33309817
[TBL] [Abstract][Full Text] [Related]
12. Muscle Strength, Size, and Composition Following 12 Months of Gender-affirming Treatment in Transgender Individuals.
Wiik A; Lundberg TR; Rullman E; Andersson DP; Holmberg M; Mandić M; Brismar TB; Dahlqvist Leinhard O; Chanpen S; Flanagan JN; Arver S; Gustafsson T
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31794605
[TBL] [Abstract][Full Text] [Related]
13. Endometrial findings among transgender and gender nonbinary people using testosterone at the time of gender-affirming hysterectomy.
Hawkins M; Deutsch MB; Obedin-Maliver J; Stark B; Grubman J; Jacoby A; Jacoby VL
Fertil Steril; 2021 May; 115(5):1312-1317. PubMed ID: 33583596
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Gender-Affirming Hormone Therapy on Serum Creatinine in Transgender Individuals.
Maheshwari A; Dines V; Saul D; Nippoldt T; Kattah A; Davidge-Pitts C
Endocr Pract; 2022 Jan; 28(1):52-57. PubMed ID: 34474185
[TBL] [Abstract][Full Text] [Related]
15. Effects of cross-sex hormone treatment on transgender women and men.
Deutsch MB; Bhakri V; Kubicek K
Obstet Gynecol; 2015 Mar; 125(3):605-610. PubMed ID: 25730222
[TBL] [Abstract][Full Text] [Related]
16. Endocrinological and ovarian histological investigations in assigned female at birth transgender people undergoing testosterone therapy.
Borrás A; Manau MD; Fabregues F; Casals G; Saco A; Halperin I; Mora M; Goday A; Barral Y; Carmona F
Reprod Biomed Online; 2021 Aug; 43(2):289-297. PubMed ID: 34244072
[TBL] [Abstract][Full Text] [Related]
17. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
Wiepjes CM; Nota NM; de Blok CJM; Klaver M; de Vries ALC; Wensing-Kruger SA; de Jongh RT; Bouman MB; Steensma TD; Cohen-Kettenis P; Gooren LJG; Kreukels BPC; den Heijer M
J Sex Med; 2018 Apr; 15(4):582-590. PubMed ID: 29463477
[TBL] [Abstract][Full Text] [Related]
18. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
